LNTH
Lantheus Holdings IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$6.71B
P/E Ratio
24.58
EPS
$4.19
Beta
-0.08
52W High
$103.89
52W Low
$47.25
50-Day MA
$83.95
200-Day MA
$66.77
Dividend Yield
—
Profit Margin
18.00%
Forward P/E
18.18
PEG Ratio
0.61
About Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
Fundamentals
| Revenue (TTM) | $1.55B |
| Gross Profit (TTM) | $935.17M |
| EBITDA | $366.26M |
| Operating Margin | 21.60% |
| Return on Equity | 23.50% |
| Return on Assets | 8.15% |
| Revenue/Share (TTM) | $23.25 |
| Book Value | $18.63 |
| Price-to-Book | 5.54 |
| Price-to-Sales (TTM) | 4.34 |
| EV/Revenue | 4.424 |
| EV/EBITDA | 14.47 |
| Quarterly Earnings Growth (YoY) | 76.50% |
| Quarterly Revenue Growth (YoY) | 1.20% |
| Shares Outstanding | $65.11M |
| Float | $58.38M |
| % Insiders | 2.09% |
| % Institutions | 115.61% |
Historical Volatility
HV 10-Day
51.40%
HV 20-Day
45.94%
HV 30-Day
39.42%
HV 60-Day
42.34%
HV Rank
48.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($104.08 target)
2
Strong Buy9
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026